COMMUNIQUÉS West-GlobeNewswire

Orion receives Lean Prize 2016
05/10/2017
ORION CORPORATION PRESS RELEASE 5 OCT 2017 at 12:35 EEST Orion receives Lean Prize 2016 As the cost pressures on pharmaceutical companies increase, Orion needs to constantly improve its efficiency to stay competitive. [...]
DRGT announces results of Phase I study expanding clinical utility of the drug Sirolimus utilizing the company's novel Super-API technology platform
05/10/2017
MSIDA, Malta, Oct. 05, 2017 (GLOBE NEWSWIRE) -- DRGT, a specialty pharmaceutical company, today announced the results of its Phase I study of DRGT18-2, a novel formulation of Sirolimus (Rapamune®), originally a Pfizer [...]
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
05/10/2017
FIT Biotech Oy Company release October 5, 2017 at 10:00 AM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on September 26, 2016 [...]
Solon Eiendom ASA : Primary insider notification
05/10/2017
(Oslo, Norway, 4 October 2017) Solon Eiendom ASA Board Member Tore Aksel Voldberg (through his wholly owned company Skøien AS) has today bought 1 000 shares in Solon Eiendom ASA at a price of NOK 18,5000. Following this [...]
FIT Biotech Oy: FIT Biotech initiates gene therapy research collaboration with Avacta
05/10/2017
FIT Biotech Oy Company release 05.10.2017 at 9.00 EET FIT Biotech initiates gene therapy research collaboration with Avacta FIT Biotech Oy ("Company") today announced that it has initiated a research collaboration with [...]
MDxHealth Opens New Service and Research Laboratory in The Netherlands
05/10/2017
COMPANY ANNOUNCEMENT HERSTAL, BELGIUM - 07:00 CEST, October 5, 2017 - MDxHealth SA (Euronext: MDXH.BR) today announced the opening of its new service and research laboratory at the Novio Tech Campus in Nijmegen, the [...]
MDxHealth ouvre un nouveau laboratoire de service et de recherche aux Pays-Bas
05/10/2017
Annonce d'entreprise HERSTAL, BELGIQUE - 07:00 CEST, 5 octobre 2017 - MDxHealth SA (Euronext: MDXH.BR) a annoncé l'ouverture de son nouveau laboratoire de service et de recherche, au Novio Tech Campus de Nimègue, aux [...]
TiGenix to present positive 52-week Phase III results of Cx601 at World Congress of Gastroenterology at ACG 2017 meeting
05/10/2017
PRESS RELEASE TiGenix to present positive 52-week Phase III results of Cx601 at World Congress of Gastroenterology at ACG 2017 meeting Leuven (BELGIUM) - October 5, 2017, 07:00h CET - TiGenix NV (Euronext Brussels and [...]
TiGenix présentera les résultats favorables de la semaine 52 de l'essai de phase III de Cx601 à l'occasion du Congrès Mondial de Gastro-entérologie à ACG 2017
05/10/2017
COMMUNIQUÉ DE PRESSE TiGenix présentera les résultats favorables de la semaine 52 de l'essai de phase III de Cx601 à l'occasion du Congrès Mondial de Gastro-entérologie à ACG 2017 Louvain (BELGIQUE) - 5 octobre 2017, [...]
PCI Biotech receives US Orphan Drug Designation for fimaporfin in the treatment of bile duct cancer (cholangiocarcinoma)
04/10/2017
Oslo, 4 October 2017 - PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to its lead product [...]
Abeona Therapeutics Announces Dedication of Commercial Gene Therapy Manufacturing Facility in Cleveland, Ohio
04/10/2017
-- Facility to support development of advanced gene and cell therapies for treatment of life-threatening rare diseases -- Leaders from local government, life sciences and medical technology to join on October 4 for [...]
EDAP Announces FDA Clearance of its Ablatherm-Fusion® device
04/10/2017
LYON, France, October 4, 2017 -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced FDA approval of its Ablatherm-Fusion device enabling a more precise method for targeting of [...]
Immunocore Appoints Andrew Hotchkiss as Chief Commercial Officer
04/10/2017
PRESS RELEASE Immunocore Appoints Andrew Hotchkiss as Chief Commercial Officer (Oxford, UK and Conshohocken, US, 4 October 2017) Immunocore Limited, the world's leading TCR company developing biological drugs to treat [...]
Summit Highlights DMD Biomarker Validation Data at 22nd WMS Congress
04/10/2017
Summit Therapeutics plc ('Summit', or 'the Company') SUMMIT HIGHLIGHTS DMD BIOMARKER VALIDATION DATA AND PHASE 2 CLINICAL TRIAL BASELINE CHARACTERISTICS IN PRESENTATIONS AT 22ND WMS CONGRESS Oxford, UK, 4 October 2017 [...]
Zealand Pharma and Torrey Pines Institute for Molecular Studies announce research collaboration
04/10/2017
Press release - No. 8/2017 Zealand Pharma and Torrey Pines Institute for Molecular Studies announce research collaboration Combining expertise in discovery and development of peptide therapeutics with unique peptide [...]
Ambu A/S: Ambu launches ambitious strategy towards 2020
04/10/2017
After exceeding the goals of the 2017 strategy, Ambu sets new goals and aims to double revenue in just three years. The key elements are a stable core business and disruptive single-use endoscopy technology. In 2013, [...]
Immunocore Appoints Andrew Hotchkiss as Chief Commercial Officer
04/10/2017
PRESS RELEASE Immunocore Appoints Andrew Hotchkiss as Chief Commercial Officer (Oxford, UK and Conshohocken, US, 4 October 2017) Immunocore Limited, the world's leading TCR company developing biological drugs to treat [...]
XBiotech annonce l'ajout du dermatologue renommé, le Dr William Levis, à son Conseil scientifique consultatif
04/10/2017
AUSTIN, Texas, le 4 octobre 2017 (GLOBE NEWSWIRE). - XBiotech Inc. (NASDAQ : XBIT) est heureuse d'annoncer la nomination de William Levis, MD, à son Conseil scientifique consultatif (Scientific Advisory Board - SAB). Le [...]
KARO PHARMA AB'S TAKEOVER OFFER FOR WEIFA ASA SUCCESSFUL
03/10/2017
On expiration of the offer period on 3 October, 2017 at 16:30 CEST, Karo Pharma AB ("Karo Pharma") had received acceptances for the voluntary offer ("Voluntary Offer") to acquire all shares in Weifa ASA ("Weifa") for a [...]

Pages